221 related articles for article (PubMed ID: 31800580)
1. Consumption of psychoactive substances in prison: Between initiation and improvement, what trajectories occur after incarceration? COSMOS study data.
Rousselet M; Guerlais M; Caillet P; Le Geay B; Mauillon D; Serre P; Chameau PY; Bleher Y; Mounsande S; Jolliet P; Victorri-Vigneau C
PLoS One; 2019; 14(12):e0225189. PubMed ID: 31800580
[TBL] [Abstract][Full Text] [Related]
2. Use of psychoactive substances in prison: Results of a study in the Lyon-Corbas prison, France.
Sahajian F; Berger-Vergiat A; Pot E
Rev Epidemiol Sante Publique; 2017 Sep; 65(5):361-367. PubMed ID: 28886958
[TBL] [Abstract][Full Text] [Related]
3. Consumption of psychoactive substances among 535 women entering a Lyon prison (France) between June 2004 and December 2008.
Sahajian F; Lamothe P; Fabry J; Vanhems P
Rev Epidemiol Sante Publique; 2012 Oct; 60(5):371-81. PubMed ID: 22981309
[TBL] [Abstract][Full Text] [Related]
4. Illicit substance use after release from prison among formerly incarcerated primary care patients: a cross-sectional study.
Chamberlain A; Nyamu S; Aminawung J; Wang EA; Shavit S; Fox AD
Addict Sci Clin Pract; 2019 Feb; 14(1):7. PubMed ID: 30782211
[TBL] [Abstract][Full Text] [Related]
5. [Prevalence and predictors of psychoactive substance use among men in prisons].
Caravaca-Sánchez F; Falcón Romero M; Luna A
Gac Sanit; 2015; 29(5):358-63. PubMed ID: 26228003
[TBL] [Abstract][Full Text] [Related]
6. Pre-incarceration police harassment, drug addiction and HIV risk behaviours among prisoners in Kyrgyzstan and Azerbaijan: results from a nationally representative cross-sectional study.
Polonsky M; Azbel L; Wegman MP; Izenberg JM; Bachireddy C; Wickersham JA; Dvoriak S; Altice FL
J Int AIDS Soc; 2016; 19(4 Suppl 3):20880. PubMed ID: 27435715
[TBL] [Abstract][Full Text] [Related]
7. [Psychoactive substance use among newly incarcerated prison inmates].
Sahajian F; Lamothe P; Fabry J
Sante Publique; 2006 Jun; 18(2):223-34. PubMed ID: 16886546
[TBL] [Abstract][Full Text] [Related]
8. [Risk of incarceration of persons undergoing psychiatric care. A retrospective longitudinal study on the French department of Oise using information from a psychiatric hospital discharge database].
Plancke L; Gonfroy J; Lancelevée C; Danel T; Delaplace C; Fovet T; Thomas P; Amariei A
Rev Epidemiol Sante Publique; 2020 Nov; 68(6):367-373. PubMed ID: 33131979
[TBL] [Abstract][Full Text] [Related]
9. Medicaid Enrollment among Prison Inmates in a Non-expansion State: Exploring Predisposing, Enabling, and Need Factors Related to Enrollment Pre-incarceration and Post-Release.
Grodensky CA; Rosen DL; Blue CM; Miller AR; Bradley-Bull S; Powell WA; Domino ME; Golin CE; Wohl DA
J Urban Health; 2018 Aug; 95(4):454-466. PubMed ID: 29934825
[TBL] [Abstract][Full Text] [Related]
10. Drugs in prison: a break in the pathway.
Plourde C; Brochu S
Subst Use Misuse; 2002 Jan; 37(1):47-63. PubMed ID: 11848159
[TBL] [Abstract][Full Text] [Related]
11. Mental health of jail inmates within the prison of Ducos, Martinique - a cross-sectional descriptive study.
Arnal R; Spodenkiewicz M; Lacoste J; Jehel L; Falissard B
Rev Epidemiol Sante Publique; 2018 May; 66(3):201-207. PubMed ID: 29685697
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and correlates of in-prison substance use among incarcerated women in Spain.
Sánchez FC; Fearn N; Vaughn MG
J Ethn Subst Abuse; 2018; 17(3):356-374. PubMed ID: 28166472
[TBL] [Abstract][Full Text] [Related]
13. Predictors of drug use in prison among incarcerated Black men.
Rowell TL; Wu E; Hart CL; Haile R; El-Bassel N
Am J Drug Alcohol Abuse; 2012 Nov; 38(6):593-7. PubMed ID: 22746253
[TBL] [Abstract][Full Text] [Related]
14. The Prison and Transition Health (PATH) Cohort Study: Study Protocol and Baseline Characteristics of a Cohort of Men with a History of Injecting Drug Use Leaving Prison in Australia.
Kirwan A; Curtis M; Dietze P; Aitken C; Woods E; Walker S; Kinner S; Ogloff J; Butler T; Stoové M
J Urban Health; 2019 Jun; 96(3):400-410. PubMed ID: 30989484
[TBL] [Abstract][Full Text] [Related]
15. Maintenance therapy and 3-year outcome of opioid-dependent prisoners: a prospective study in France (2003-06).
Marzo JN; Rotily M; Meroueh F; Varastet M; Hunault C; Obradovic I; Zin A
Addiction; 2009 Jul; 104(7):1233-40. PubMed ID: 19426291
[TBL] [Abstract][Full Text] [Related]
16. Adding Spice to the Porridge: The development of a synthetic cannabinoid market in an English prison.
Ralphs R; Williams L; Askew R; Norton A
Int J Drug Policy; 2017 Feb; 40():57-69. PubMed ID: 27955961
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with psychoactive substance use among a sample of prison inmates in Ilesa, Nigeria.
Amdzaranda PA; Fatoye FO; Oyebanji AO; Ogunro AS; Fatoye GK
Niger Postgrad Med J; 2009 Jun; 16(2):109-14. PubMed ID: 19606190
[TBL] [Abstract][Full Text] [Related]
18. Factors Affecting Drug Use During Incarceration: A Cross-Sectional Study of Opioid-Dependent Persons from India.
Rao R; Mandal P; Gupta R; Ramshankar P; Mishra A; Ambekar A; Jhanjee S; Dhawan A
J Subst Abuse Treat; 2016 Feb; 61():13-7. PubMed ID: 26470597
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of addictive behaviours among new prisoners in France using the OPPIDUM program].
Pauly V; Frauger E; Rouby F; Sirere S; Monier S; Paulet C; Gibaga V; Micallef J; Thirion X
Encephale; 2010 Apr; 36(2):122-31. PubMed ID: 20434629
[TBL] [Abstract][Full Text] [Related]
20. Predictors of Illicit Drug Use Among Prisoners.
Rowell-Cunsolo TL; Sampong SA; Befus M; Mukherjee DV; Larson EL
Subst Use Misuse; 2016 Jan; 51(2):261-7. PubMed ID: 26789438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
